Search results for Vantictumab
Showing 1 – 10 of3products

ID: BAB484428497
Vantictumab, Abbexa, abx831287
Vantictumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting FZD, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Vantictumab has been used in trials studying the treatment of Solid Tumors, Pancreatic Cancer, and Stage IV Pancreatic Cancer.
Host
Human
Reactivity
Human
Applications
ELISA, WB
Conjugation
Unconjugated

ID: BAB577655679
Vantictumab Biosimilar - Research Grade, ichor.bio, ICH5967
Host
CHO Cells
Reactivity
Human
Applications
Conjugation

ID: BAB615937295
Research Grade Vantictumab (HV162016), abinScience, HV162016
Host
Human
Reactivity
Human
Applications
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Conjugation
Request a product
Please provide the required information below so that we can quickly source your products.
